Lenalidomide for untreated follicular lymphoma ID1245
Discontinued
Reference number: GID-TA10308
The Department for Health and Social Care has asked NICE to carry out a Single Technology Appraisal (STA) of lenalidomide within its marketing authorisation for treating follicular, untreated lymphoma.
Following a recent update from the company, NICE has decided to suspend this appraisal on its work programme.
As the appraisal has been referred, NICE will continue to monitor any developments and will provide a further update in due course.